The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Purpose To study the uptake of biodegradable microparticles in Caco-2 cells.Methods Biodegradable microparticles of polylactic polyglycolic acid co-polymer (PLGA 50:50) of mean diameters 0.1 micron, 1 micron, and 10 microns containing bovine serum albumin as a model protein and 6-coumarin as a fluorescent marker were formulated by a multiple emulsion technique. The Caco-2 cell monolayers were incubated with each diameter microparticles (100 micrograms/ml) for two hours. The microparticle uptake in Caco-2 cells was studied by confocal microscopy and also by quantitating the 6-coumarin content of the microparticles taken up by the cells. The effects of microparticle concentration, and incubation time and temperature on microparticle cell uptake were also studied.Results The study demonstrated that the Caco-2 cell microparticle uptake significantly depends upon the microparticle diameter. The 0.1 micron diameter microparticles had 2.5 fold greater uptake on the weight basis than the 1 micron and 6 fold greater than the 10 microns diameter microparticles. Similarly in terms of number the uptake of 0.1 micron diameter microparticles was 2.7 x 10(3) fold greater than the 1 micron and 6.7 x 10(6) greater than the 10 microns diameter microparticles. The efficiency of uptake of 0.1 micron diameter microparticles at 100 micrograms/ml concentration was 41% compared to 15% and 6% for the 1 micron and the 10 microns diameter microparticles, respectively. The Caco-2 cell microparticle (0.1 micron) uptake increased with concentration in the range of 100 micrograms/ml to 500 micrograms/ml which then reached a plateau at higher concentration. The uptake of microparticles increased with incubation time, reaching a steady state at two hours. The uptake was greater at an incubation temperature of 37 degrees C compared to at 4 degrees C.Conclusions The Caco-2 cell microparticle uptake was microparticle diameter, concentration, and incubation time and temperature dependent. The small diameter microparticles (0.1 micron) had significantly greater uptake compared to larger diameter microparticles. The results thus suggest that the mechanism of uptake of microparticles in Caco-2 cell is particle diameter dependent. Caco-2 cells are used as an in vitro model for gastrointestinal uptake, and therefore the results obtained in these studies could be of significant importance in optimizing the microparticle-based oral drug delivery systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The capacity of transcytosis through the intestinal epithelial layer depends on the size, with a particle size of below 1 μm for optimal M-cell absorption [30], but also on the charge and hydrophilicity of the particle carrier [31–33].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [32]
Citations
Cites
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Self-citationArtursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844
Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Nano- and microparticles for the delivery of polypeptides and proteins
Couvreur, P., & Puisieux, F. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90046-7 · Cited by 281
A Novel Approach to the Oral Delivery of Micro- or Nanoparticles
Bodmeier, R., Chen, H., & Paeratakul, O. (1989) · Pharmaceutical Research · doi:10.1023/a:1015987516796 · Cited by 276
Walter, E., Janich, S., Roessler, B. J., Hilfinger, J. M., & Amidon, G. L. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960110x · Cited by 273
Self-citationThe Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies
Audus, K. L., Bartel, R. L., Hidalgo, I. J., & Borchardt, R. T. (1990) · Pharmaceutical Research · doi:10.1023/a:1015800312910 · Cited by 267
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
Florence, A. T., Hillery, A. M., Hussain, N., & Jani, P. U. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00059-h · Cited by 260
Peroral administration of nanoparticles
Kreuter, J. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90048-h · Cited by 207
Research works printed but not linked: 2
- J. Kreuter. J. Anat. 189:503–505, 1996.
- R. H. Muller. Colloidal Carriers for Controlled Drug Delivery and Targeting CRC Press, Boston, 1991.
Cited by
Items 201–300 of 872
Lin, A., Sabnis, A., Kona, S., Nattama, S., Patel, H., Dong, J., & Nguyen, K. T. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32592 · Cited by 94
Işık, B. Ş., Altay, F., & Çapanoğlu, E. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.05.064 · Cited by 96
Chalew, T. E. A., & Schwab, K. J. (2013) · Cell Biology and Toxicology · doi:10.1007/s10565-013-9241-6 · Cited by 101
Santander-Ortega, M. J., Peula-García, J. M., Goycoolea, F. M., & Ortega-Vinuesa, J. L. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.10.019 · Cited by 91
Recombinant human gelatin nanoparticles as a protein drug carrier
Won, Y.-W., & Kim, Y. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.010 · Cited by 91
“5 fold greater than 1 μm size particles and six fold greater than 10 μm particles [2].”
BackgroundYuan, H., & Zhang, S. (2010) · Applied Physics Letters · doi:10.1063/1.3293303 · Cited by 90
Preparation and evaluation of PEG–PCL nanoparticles for local tetradrine delivery
Li, R., Li, X., Li, X., Ding, D., Hu, Y., Qian, X., Yu, L., Ding, Y., Jiang, X., & Liu, B. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.007 · Cited by 93
“Cellular uptake studies Particles loading fluorescent dyes are frequently used to study ellular uptake (Desai et al., 1997; Hu et al., 2007; Panyam et al., 003).”
BackgroundTissue Engineering Using Ceramics and Polymers
Gough, J. E. (2007) · CRC Press eBooks · doi:10.1201/9781439823989 · Cited by 96
An appraisal of the published literature on the safety and toxicity of food-related nanomaterials
Card, J. W., Jonaitis, T. S., Tafazoli, S., & Magnuson, B. A. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.524636 · Cited by 87
“…on the size of the particles; the smaller the particle diameter, the faster they may diffuse through GI secretion to reach the colonic enterocytes (Jani et al�, 1990; Desai et al�, 1996, 1997; Szentkuti, 1997)� For example, polystyrene microspheres in the size range of 50 nm to 3 μm were…”
BackgroundEl-Zayat, M. M., Eraqi, M. M., Alrefai, H., El-Khateeb, A. Y., Ibrahim, M. A., Aljohani, H. M., Aljohani, M. M., & Elshaer, M. M. (2021) · Biomolecules · doi:10.3390/biom11030470 · Cited by 97
“The nano-size of these materials allows an efficient uptake by various cell types and selective drug accumulation at target sites [66].”
BackgroundBoyes, W. K., Thornton, L. L., Al‐Abed, S. R., Andersen, C. P., Bouchard, D. C., Burgess, R. M., Hubal, E. A. C., Ho, K. T., Hughes, M. F., Kitchin, K. T., et al. (2017) · Critical Reviews in Toxicology · doi:10.1080/10408444.2017.1328400 · Cited by 94
“1996, 1997) have reported polylactic polyglycolic acid co-polymer particles of size 100 nm–10 lm show decreased absorption with increased size of particle in vitro whether in the rat in situ intestinal loop model or in Caco-2 cells (Desai et al. 1997).”
BackgroundInfluentialSuciu, M., Ionescu, C. M., Ciorîţă, A., Tripon, S. C., Nica, D. V., Al‐Salami, H., & Barbu–Tudoran, L. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.94 · Cited by 92
The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats
Zhang, Q.-Z., Zha, L.-S., Zhang, Y., Jiang, W.-M., Lu, W., Shi, Z.-Q., Jiang, X.-G., & Fu, S.-K. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600721051 · Cited by 87
“Particles smaller than 100 nm, in general, have higher transport (Jani et al. 1989; Desai et al. 1997; Brooking et al. 2001).”
BackgroundMohammady, M., Mohammadi, Y., & Yousefi, G. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.07.015 · Cited by 96
Banaei, G., García‐Rodríguez, A., Tavakolpournegari, A., Martín-Pérez, J., Villacorta, A., Marcos, R., & Hernández, A. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131899 · Cited by 93
Tomoda, K., Watanabe, A., Suzuki, K., Inagi, T., Terada, H., & Makino, K. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.04.002 · Cited by 87
Bruckman, M. A., Czapar, A. E., VanMeter, A., Randolph, L. N., & Steinmetz, N. F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.045 · Cited by 95
“4 and receptor diffusion kinetics, the optimum radius for cellular uptake lies at r = 30 nm (viruses were used as model systems in several of these studies) [30, 31, 34-40].”
Non-viral gene delivery using nanoparticles
Ditto, A. J., Shah, P. N., & Yun, Y. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903241796 · Cited by 87
“3 Nanoparticles Nanoparticles are ideal candidates for intracellular gene vectors because they can be tailored for a sustained delivery of genes, and their sizes generally vary from 10 to 1000 nm, which means eukaryotic cells can internalize them [38,39].”
BackgroundCavalli, R., Donalisio, M., Civra, A., Ferruti, P., Ranucci, E., Trotta, F., & Lembo, D. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.004 · Cited by 87
Silk Fibroin-Based Therapeutics for Impaired Wound Healing
Lehmann, T., Vaughn, A. E., Seal, S., Liechty, K. W., & Zgheib, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030651 · Cited by 91
Application of Outer Membrane Protein-Based Vaccines Against Major Bacterial Fish Pathogens in India
Maiti, B., Dubey, S., Munang’andu, H. M., Karunasagar, I., Karunasagar, I., & Evensen, Ø. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01362 · Cited by 84
Biogenic Selenium Nanoparticles in Animal Nutrition: A Review
Malyugina, S., Skalíčková, S., Skládanka, J., Sláma, P., & Horký, P. (2021) · Agriculture · doi:10.3390/agriculture11121244 · Cited by 84
“1 μm was found to be higher than 1 and 10 μm NPs [102].”
BackgroundOyewumi, M. O., & Mumper, R. J. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00587-2 · Cited by 84
Co-delivery of docetaxel and Poloxamer 235 by PLGA–TPGS nanoparticles for breast cancer treatment
Tang, X., Liang, Y., Feng, X., Zhang, R., Jin, X., & Sun, L. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.01.033 · Cited by 88
“Evidences have demonstrated that nanoparticle has a size-dependent effect on cellular uptake of biodegradable microparticles or nanoparticles [31,32].”
BackgroundThe role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells
Tran, K. K., & Shen, H. Y. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.034 · Cited by 84
“Since particle size also affects the amount of antigen uptake by cells [19], the enhancement observed can be attributed to both the efficiency of intracellular antigen processing and presentation and the total amount of antigen taken up by cells.”
BackgroundTsai, Y. H., Mao, S., Li, M., Huang, J. T., & Lien, T. F. (2016) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2016.01.009 · Cited by 84
Tomoda, K., Terashima, H., Suzuki, K., Inagi, T., Terada, H., & Makino, K. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.11.016 · Cited by 83
Multicompartmental Particles for Combined Imaging and siRNA Delivery
Misra, A. C., Bhaskar, S., Clay, N. E., & Lahann, J. (2012) · Advanced Materials · doi:10.1002/adma.201200372 · Cited by 89
Nehilla, B. J., Allen, P. G., & Desai, T. A. (2008) · ACS Nano · doi:10.1021/nn700281b · Cited by 81
Maßgeschneiderte Nanopartikel für den Wirkstofftransport in der Krebstherapie
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie · doi:10.1002/ange.201403036 · Cited by 86
In-vivo tumor targeting of pluronic-based nano-carriers
Kim, J., Choi, W. I., Kim, Y., Tae, G., Lee, S. Y., Kim, K., & Kwon, I. C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.010 · Cited by 82
Dong, Y., & Feng, S. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30684 · Cited by 81
Wang, M. Q., Xu, Z., Zha, L., & Lindemann, M. D. (2007) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2006.12.004 · Cited by 80
“, 1996), and the significantly greater uptake of small diameter microparticles and size dependency of uptake were confirmed in Caco-2 cell lines (Desai et al., 1997).”
BackgroundZhang, X.-Q., Dahle, C. E., Baman, N. K., Rich, N., Weiner, G. J., & Salem, A. K. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31802fd8c6 · Cited by 79
“The general trend is that smaller particles are more efficiently internalized than larger particles.(30) This is also consistent with the observations from Manzel and Macfarlane(31) that showed an immune response was not generated when CpG ODN was bound to particles that were larger than the cells, presumably owing to…”
ResultSelf-assembled nanoparticles of poly(lactide)–Vitamin E TPGS copolymers for oral chemotherapy
ZHANG, Z., & FENG, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.013 · Cited by 81
Puri, S., Kallinteri, P., Higgins, S. J., Hutcheon, G. A., & Garnett, M. C. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.009 · Cited by 85
Chakraborty, I., Carrington, S. J., Hauser, J. L., Oliver, S. R. J., & Mascharak, P. K. (2015) · Chemistry of Materials · doi:10.1021/acs.chemmater.5b03859 · Cited by 78
Shah, S. S., Pal, A., Kaushik, V. K., & Devi, S. (2009) · Journal of Applied Polymer Science · doi:10.1002/app.29807 · Cited by 78
Chowdhury, S., Kar, K., & Mazumder, R. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00644-y · Cited by 77
“This helps to determine the particle range and its concentration within a matrix [78].”
BackgroundLiao, C.-D., Hung, W., Jan, K., Yeh, A., Ho, C., & Hwang, L. S. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2009.07.056 · Cited by 77
Mondon, K., Labouebe, M. Z., Gurny, R., & Möller, M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.09.012 · Cited by 76
“For other pathological sites, the nanosize of micelles allows for better internalization in cells and increases the therapeutic effect of the drug compared to larger carriers [8–10].”
BackgroundWang, M. Q., & Xu, Z. (2004) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.2004.1118 · Cited by 76
“Though there is few studies on mechanism of uptake of nanoparticles, Desai et al. (1997) reported that in some cell lines (e.g. Caco-2), nanoparticles showed relatively greater efficacy of uptake than microparticles.”
BackgroundMiriyala, N., Ouyang, D., Perrie, Y., Lowry, D., & Kirby, D. J. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.03.002 · Cited by 77
“1–10 lm) by endocytosis has also been observed [44,45].”
MethodSpecific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages
Brandhonneur, N., Chevanne, F., Vié, V., Frisch, B., Primault, R., Le Potier, M.-F., & Le Corre, P. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.11.013 · Cited by 75
Zhang, X., Pan, W., Gan, L., Zhu, C., Gan, Y., & Nie, S. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.1645 · Cited by 75
Disease, destination, dose and delivery aspects of ciclosporin: the state of the art
Italia, J. L., Bhardwaj, V., & Kumar, M. N. V. R. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.015 · Cited by 85
A comparison of anionic nanoparticles and microparticles as vaccine delivery systems
Wendorf, J. R., Chesko, J., Kazzaz, J., Ugozzoli, M., Vajdy, M., O’Hagan, D. T., & Singh, M. (2008) · Human Vaccines · doi:10.4161/hv.4.1.4886 · Cited by 75
Musyanovych, A., Dausend, J., Dass, M., Walther, P., Mailänder, V., & Landfester, K. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.07.033 · Cited by 88
Li, M., Huang, J., Tsai, Y., Mao, S., Fu, C., & Lien, T. (2016) · Animal Science Journal · doi:10.1111/asj.12579 · Cited by 74
Jin, C. S., Bai, L., Wu, H., Tian, F., & Guo, G. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.032 · Cited by 74
Novel Bioactive Extraction and Nano-Encapsulation
Noore, S., Rastogi, N. K., O’Donnell, C. P., & Tiwari, B. K. (2021) · Encyclopedia · doi:10.3390/encyclopedia1030052 · Cited by 82
“Additionally, the strength of bioactive compound to remain stable can be examined by placing them in a modified environment including high/low temperature, different ionic charge fluids and different pH range [177].”
BackgroundPurified and surfactant-free coenzyme Q10-loaded biodegradable nanoparticles
Nehilla, B. J., BERGKVIST, M., Popat, K. C., & Desai, T. A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.001 · Cited by 73
Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer
Sims, L. B., Curtis, L. T., Frieboes, H. B., & Steinbach-Rankins, J. M. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0185-x · Cited by 79
“From earlier studies [72–75] as well as our previous experiments, we have observed that negligible quantities (~1 %) of C6 are released from NPs.”
Górska, S., Maksymiuk, A., & Turło, J. (2021) · Applied Sciences · doi:10.3390/app11083717 · Cited by 77
Advances in nanoparticle synthesis assisted by microfluidics
Saeed, M. M., Carthy, É., Dunne, N., & Kinahan, D. J. (2025) · Lab on a Chip · doi:10.1039/d5lc00194c · Cited by 79
Oral vaccination in man using antigens in particles: current status
Brayden, D. J. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00175-0 · Cited by 72
Mandal, B., Alexander, K. S., & Riga, A. T. (2010) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3sw2t · Cited by 83
Li, Q., Du, Y., Yuan, H., Zhang, X., Miao, J., Cui, F., & Hu, F. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.08.004 · Cited by 75
Alfei, S., Marengo, B., Zuccari, G., Turrini, F., & Domenicotti, C. (2020) · Nanomaterials · doi:10.3390/nano10061243 · Cited by 71
“The preferential size, for successful biomedical applications and for assuring an efficient cellular up-take, has to be less than 200 nm, with an optimal of 100–200 nm [85,86].”
BackgroundPolymer-based Oral Peptide Nanomedicines
Pérez‐Herrero, E., Alonso, M. J., & Csaba, N. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.40 · Cited by 74
Woitiski, C. B., Carvalho, R. A., Ribeiro, A. J., Neufeld, R. J., & Veiga, F. (2008) · BioDrugs · doi:10.2165/00063030-200822040-00002 · Cited by 78
Probing mechanical principles of cell–nanomaterial interactions
Gao, H. (2013) · Journal of the Mechanics and Physics of Solids · doi:10.1016/j.jmps.2013.08.018 · Cited by 70
Bulmer, C., Margaritis, A., & Xenocostas, A. (2012) · Biochemical Engineering Journal · doi:10.1016/j.bej.2012.07.007 · Cited by 77
Unique Uptake of Acid-Prepared Mesoporous Spheres by Lung Epithelial and Mesothelioma Cells
Blumen, S. R., Cheng, K., Ramos‐Niño, M. E., Taatjes, D. J., Weiss, D. J., Landry, C. C., & Mossman, B. T. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0319oc · Cited by 68
Dembri, A., Montisci, M., Gantier, J.-C., Chacun, H., & Ponchel, G. (2001) · Pharmaceutical Research · doi:10.1023/a:1011050209986 · Cited by 68
“Second, particle uptake has been reported to occur to some extent not only in Caco-2 cell cultures ( 15 ) but also in the mucosa (16), the M cells (17) of Peyer’s patches, and even in the lymphatics (18).”
BackgroundWang, Z., Cui, K., Costabel, U., & Zhang, X. (2022) · Exploration · doi:10.1002/exp.20210082 · Cited by 67
Size-Dependent Partitioning of Nano/Microparticles Mediated by Membrane Lateral Heterogeneity
Hamada, T., Morita, M., Miyakawa, M., Sugimoto, R., Hatanaka, A., Vestergaard, M. C. M., & Takagi, M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301264v · Cited by 67
Labhasetwar, V. D., Bonadio, J. F., Goldstein, S. A., & Levy, R. J. (1999) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(99)00079-x · Cited by 67
Self-citationCao, J., Xie, X., Lu, A., He, B., Chen, Y., Gu, Z., & Luo, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.067 · Cited by 67
“This result supported the finding in the literature that the extent of particle uptake was not proportional to the particle size [7,26].”
ResultInteraction of curcumin with phosphocasein micelles processed or not by dynamic high-pressure
Benzaria, A., Maresca, M., Taïeb, N., & Dumay, E. M. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.12.017 · Cited by 67
Intercalation of anti-inflammatory drug molecules within TiO2 nanotubes
Shokuhfar, T., Sinha‐Ray, S., Sukotjo, C., & Yarin, A. L. (2013) · RSC Advances · doi:10.1039/c3ra42173b · Cited by 70
Natchus, M. G., Bookland, R. G., De, B., Almstead, N. G., Pikul, S., Janusz, M. J., Heitmeyer, S. A., Hookfin, E. B., Hsieh, L. C., Dowty, M. E., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000246e · Cited by 66
Lynch, I. (2007) · Physica A: Statistical Mechanics and its Applications · doi:10.1016/j.physa.2006.06.008 · Cited by 50
Multicomponent Organic Nanoparticles for Fluorescence Studies in Biological Systems
McDonald, T. O., Martin, P., Patterson, J. P., Smith, D., Giardiello, M., Marcello, M., See, V., O'Reilly, R. K., Owen, A., & Rannard, S. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201103059 · Cited by 63
Mechanisms of uptake and transport of particulate formulations in the small intestine
Delon, L., Gibson, R. J., Prestidge, C. A., & Thierry, B. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.006 · Cited by 64
Microparticle vaccine approaches to stimulate mucosal immunisation
Brayden, D. J., & Baird, A. W. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01445-9 · Cited by 64
Saw, W. S., Ujihara, M., Chong, W. Y., Voon, S. H., Imae, T., Kiew, L. V., Lee, H. B., Sim, K. S., & Chung, L. Y. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.10.064 · Cited by 64
Anirudhan, T. S., & Sandeep, S. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm31794j · Cited by 72
Human Embryoid Bodies Containing Nano‐ and Microparticulate Delivery Vehicles
Ferreira, L., Squier, T., Park, H., Choe, H. K., Kohane, D. S., & Langer, R. (2008) · Advanced Materials · doi:10.1002/adma.200702404 · Cited by 64
Beck‐Broichsitter, M., Thieme, M., Nguyen, J., Schmehl, T., Gessler, T., Seeger, W., Agarwal, S., Greiner, A., & Kissel, T. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.201000100 · Cited by 64
Sizing, Shaping and Pharmaceutical Applications of Polyelectrolyte Complex Nanoparticles
Müller, M. (2012) · Advances in polymer science · doi:10.1007/12_2012_170 · Cited by 68
Wikingsson, L. D. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00288-8 · Cited by 64
Bioengineering Approaches to Controlled Protein Delivery
Kobsa, S., & Saltzman, W. M. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e318165f14d · Cited by 64
Therapeutic benefits of nanoparticles in stroke
Panagiotou, S., & Saha, S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00182 · Cited by 65
Zha, L., Xu, Z., Wang, M. ‐., & Linbo, G. U. (2007) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2007.00718.x · Cited by 63
Hassanen, E. I., Morsy, E. A., Hussien, A. M., Ibrahim, M. A., & Farroh, K. Y. (2020) · Bioscience Reports · doi:10.1042/bsr20194296 · Cited by 64
Selenium-Containing Agents Acting on Cancer—A New Hope?
Garbo, S., Giacomo, S. D., Łażewska, D., Honkisz-Orzechowska, E., Sotto, A. D., Fioravanti, R., Zwergel, C., & Battistelli, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010104 · Cited by 64
Luderer, F., Löbler, M., Rohm, H. W., Gocke, C., Kunna, K., Köck, K., Kroemer, H. K., Weitschies, W., Schmitz, K., & Sternberg, K. (2010) · Journal of Biomaterials Applications · doi:10.1177/0885328209360696 · Cited by 66
“Furthermore, due to their small size, nanoparticles can be readily internalized by cells [20,21].”
BackgroundXiong, S., Zhao, X., Heng, B. C., Ng, K. W., & Loo, S. C. J. (2011) · Biotechnology Journal · doi:10.1002/biot.201000351 · Cited by 66
Uptake of oleoyl-chitosan nanoparticles by A549 cells
Zhang, J., Chen, X. G., Peng, W. B., & Liu, C. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.03.006 · Cited by 62
Nejat, H., Rabiee, M., Varshochian, R., Tahriri, M., Jazayeri, H. E., Rajadas, J., Ye, H., Cui, Z., & Tayebi, L. (2017) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2017.09.008 · Cited by 64
“Desai and colleagues [24] divulged that 100 nm size nanoparticles had a 2.”
BackgroundMagnetic Nanoparticle Drug Carriers and Their Study by Quadrupole Magnetic Field-Flow Fractionation
Williams, P. S., Carpino, F., & Zborowski, M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900018v · Cited by 62
Aukunuru, J., Ayalasomayajula, S. P., & Kompella, U. B. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021701 · Cited by 62
“Discussion Nanoparticles are colloidal polymeric particles over the range of 1 to 1000 nm in diameter, with a therapeutic agent distributed in their matrix, encapsulated in their core or simply bound to their surface (Desai et al 1997; Aukunuru & Kompella 2002).”
BackgroundGharehdaghi, E. E., Faramarzi, M. A., Amini, M. A., Najafabadi, A. R., Rezayat, S. M., & Amani, A. (2012) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2012.696269 · Cited by 61
“It has already been shown that efficacy and pharmacokinetics of nanoparticles in body mainly depends on their size, polydispersity and surface charge.([19,20]) For instance, a study about in-vivo antitumor activity of chitosan nanoparticles against sarcoma-180 and mouse hepatoma H22 denoted that the particle size make…”
BackgroundAzhdarzadeh, M., Lotfipour, F., Zakeri‐Milani, P., Mohammadi, G., & Valizadeh, H. (2012) · Europe PMC (PubMed Central) · doi:10.5681/apb.2012.003 · Cited by 75
Nanobiotechnology-based Drug Delivery in Brain Targeting
Dinda, S., & Pattnaik, G. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140608143719 · Cited by 60
“tration in comparison to conventional product at the site of targeted tissues [22].”
BackgroundBinding and Uptake of Wheat Germ Agglutinin-Grafted PLGA-Nanospheres by Caco-2 Monolayers
Weissenböck, A., Bogner, E., Wirth, M., & Gabor, F. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045247.09724.26 · Cited by 61
“Besides surface charge and hyrophobicity the amount of particles taken up into intestinal epithelia is strongly dependent on size (7,22,23).”
BackgroundLocalized topical drug delivery systems for skin cancer: Current approaches and future prospects
Gupta, N., Gupta, G. D., & Singh, D. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2022.1006628 · Cited by 64
Zhang, X., Gan, Y., Gan, L., Nie, S., & Pan, W.-S. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.8.0014 · Cited by 64
“Some researchers had demonstrated that less than 0.6% of the incorporated dye could leach out from the nanoparticles over 48 h under in-vitro sink conditions (Desai et al 1997).”
BackgroundInfluentialLe, U. M., & Cui, Z. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.002 · Cited by 60
Metadata
- Authors
- Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Amidon, Gordon L.
- Venue
- Pharmaceutical Research
- Published
- 1997-11
- Volume
- 14
- Issue
- 11
- Pages
- 1568-1573
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1664986234
- Cited by
- 858
- References
- 33
- Citations by year
- 2026: 5 · 2025: 22 · 2024: 20 · 2023: 16 · 2022: 38 · 2021: 22 · 2020: 43 · 2019: 34 · 2018: 25 · 2017: 42 · 2016: 46 · 2015: 41 · 2014: 59 · 2013: 45 · 2012: 62
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- Caco-2 cells, biodegradable microparticles, PLGA, microparticle size, intestinal absorption, bovine serum albumin, multiple emulsions, temperature dependence, concentration dependence, incubation time, intestinal epithelial cells, drug delivery systems, oral bioavailability prediction
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Cattle, Cell Membrane Permeability, Humans, Intestinal Absorption, Microspheres, Models, Biological, Particle Size, Polyglycolic Acid, Polymers, Serum Albumin, Bovine, Microscopy, Confocal, Caco-2 Cells, Lactic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.